Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasser Alatawi

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Risk Management and Healthcare Policy|April 16, 2021
Relationship Between Public Mental Health and Immune Status During the COVID-19 Pandemic: Cross-Sectional Data from Saudi ArabiaBadrah S Alghamdi, Yasser Alatawi, Fahad S Alshehri, et al.
Frontiers in Public Health|January 21, 2022
Psychological Distress During COVID-19 Curfews and Social Distancing in Saudi Arabia: A Cross-Sectional StudyBadrah S Alghamdi, Yasser Alatawi, Fahad S Alshehri, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Broad-Spectrum RAS Inhibition in Pancreatic Ductal Adenocarcinoma: Mechanistic Advances and Therapeutic PromiseFawaz E Alanazi, Yasser Alatawi, Abdullah Alattar, et al.
International Journal of Hypertension|October 31, 2019
Cost-Effectiveness of More Intensive Blood Pressure Treatment in Patients with High Risk of Cardiovascular Disease in Saudi Arabia: A Modelling Study of Meta-AnalysisZiyad Almalki, Yasser Alatawi, Adnan Alharbi, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-AnalysisYasser Alatawi, Fawaz E Alanazi, Abdullah Alattar, et al.
Frontiers in Neurology|March 5, 2025
A multicenter analysis to identify the risk factors for stroke recurrence and mortality within 1 yearEman A Alraddadi, Hashim F Alotaibi, Yasser Alatawi, et al.
Frontiers in Pharmacology|July 3, 2026
Awareness, attitudes, and self-reported clinical management of antimicrobial-associated neurocognitive adverse effects among healthcare providers in Saudi ArabiaKousalya Prabahar, Wejdan Alghamdi, Hind Alshehri, et al.
Cureus|June 9, 2022
Adherence to Hormonal Therapy in Breast Cancer Patients in Saudi Arabia: A Single-Center StudyAttiah Khobrani, Yasser Alatawi, Eshtyag Bajnaid, et al.
Drug Safety|December 3, 2017
Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System DrugsNing Cheng, Md Motiur Rahman, Yasser Alatawi, et al.
Clinical Drug Investigation|September 22, 2017
Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS)Md Motiur Rahman, Yasser Alatawi, Ning Cheng, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Risk Management and Healthcare Policy|April 16, 2021
Relationship Between Public Mental Health and Immune Status During the COVID-19 Pandemic: Cross-Sectional Data from Saudi ArabiaBadrah S Alghamdi, Yasser Alatawi, Fahad S Alshehri, et al.
Frontiers in Public Health|January 21, 2022
Psychological Distress During COVID-19 Curfews and Social Distancing in Saudi Arabia: A Cross-Sectional StudyBadrah S Alghamdi, Yasser Alatawi, Fahad S Alshehri, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Broad-Spectrum RAS Inhibition in Pancreatic Ductal Adenocarcinoma: Mechanistic Advances and Therapeutic PromiseFawaz E Alanazi, Yasser Alatawi, Abdullah Alattar, et al.
International Journal of Hypertension|October 31, 2019
Cost-Effectiveness of More Intensive Blood Pressure Treatment in Patients with High Risk of Cardiovascular Disease in Saudi Arabia: A Modelling Study of Meta-AnalysisZiyad Almalki, Yasser Alatawi, Adnan Alharbi, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-AnalysisYasser Alatawi, Fawaz E Alanazi, Abdullah Alattar, et al.
Frontiers in Neurology|March 5, 2025
A multicenter analysis to identify the risk factors for stroke recurrence and mortality within 1 yearEman A Alraddadi, Hashim F Alotaibi, Yasser Alatawi, et al.
Frontiers in Pharmacology|July 3, 2026
Awareness, attitudes, and self-reported clinical management of antimicrobial-associated neurocognitive adverse effects among healthcare providers in Saudi ArabiaKousalya Prabahar, Wejdan Alghamdi, Hind Alshehri, et al.
Cureus|June 9, 2022
Adherence to Hormonal Therapy in Breast Cancer Patients in Saudi Arabia: A Single-Center StudyAttiah Khobrani, Yasser Alatawi, Eshtyag Bajnaid, et al.
Drug Safety|December 3, 2017
Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System DrugsNing Cheng, Md Motiur Rahman, Yasser Alatawi, et al.
Clinical Drug Investigation|September 22, 2017
Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS)Md Motiur Rahman, Yasser Alatawi, Ning Cheng, et al.
Pageof 4